Sana Biotechnology (SANA) Capital Expenditures (2020 - 2026)
Sana Biotechnology (SANA) reported Capital Expenditures of $288000.0 for Q1 2026, up 111.76% on a YoY basis from $136000.0 in Q1 2025, and down 67.01% sequentially from $873000.0 in Q4 2025.
Sana Biotechnology (SANA) Capital Expenditures (2020 - 2026) Analysis & Trends
Sana Biotechnology (SANA) has 7 years of Capital Expenditures data on file, last reported at $288000.0 in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures rose 111.76% year-over-year to $288000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 113.23% YoY), and the FY2025 full-year result was $938000.0, changed N/A from the prior year.
- Capital Expenditures fell to $288000.0 in Q1 2026, from $873000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $8.5 million in Q2 2022 to a low of -$9.5 million in Q3 2022.
- A 5-year average of $701823.5 and a median of $136000.0 in 2025 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures surged 3207.0% in 2022 and sank 2141.7% in 2024, its largest moves.
- Tracing SANA's Capital Expenditures over 5 years: stood at -$1.2 million in 2022, then surged by 396.6% to $3.5 million in 2023, then plunged by 107.4% to -$258000.0 in 2024, then surged by 438.37% to $873000.0 in 2025, then slumped by 67.01% to $288000.0 in 2026.
- Business Quant data shows SANA's Capital Expenditures at $288000.0 in Q1 2026, $873000.0 in Q4 2025, and $65000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Sana Biotechnology | 888.71 Mn | 888.71 Mn | - | 288,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 288,000.00 |
| Mar 31, 2026 | 288,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Dec 31, 2025 | 873,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Sep 30, 2025 | 65,000.00 |
| Jun 30, 2025 | -136,000.00 |
| Jun 30, 2025 | -136,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Mar 31, 2025 | 136,000.00 |
| Dec 31, 2024 | -258,000.00 |
| Dec 31, 2024 | -258,000.00 |
| Sep 30, 2024 | -3.12 Mn |
| Sep 30, 2024 | -3.12 Mn |
| Jun 30, 2024 | -5.00 Mn |
| Jun 30, 2024 | -5.00 Mn |
| Mar 31, 2024 | 8.38 Mn |
| Mar 31, 2024 | 8.38 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Dec 31, 2023 | 3.49 Mn |